⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1462736 | 0.80 | TSHR (0.35) | — | |
| SCHEMBL3977096 | 0.80 | — | — | |
| SCHEMBL503862 | 0.78 | — | — | |
| SCHEMBL1888949 | 0.78 | — | — | |
| SCHEMBL2334141 | 0.76 | — | — | |
| SCHEMBL1450693 | 0.73 | TSHR (0.32) | — | |
| SCHEMBL8651465 | 0.71 | TSHR (0.30) | — | |
| SCHEMBL30420102 | 0.71 | TSHR (0.30) | — | |
| SCHEMBL10796733 | 0.70 | — | — | |
| SCHEMBL8764117 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118950081-A | Catalyst for synthesizing L-glufosinate-ammonium, and preparation method and application thereof | 山东汇盟生物科技股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-117964654-A | Synthesis method of arginate-ammonium phosphonate | 南京盛德创赢生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-118950081-A | Catalyst for synthesizing L-glufosinate-ammonium, and preparation method and application thereof | 山东汇盟生物科技股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-116284115-A | Preparation method of glufosinate-ammonium intermediate | 佳木斯黑龙农药有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115141226-B | Preparation method of 3- (methyl alkoxy phosphoryl) propionate | 浙江新安化工集团股份有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-5175344-A | Anticonvulsants, anxiolytic agents | CIBA-GEIGY CORPORATION (US) | 1992-12-29 | — | — | US | disclosed |
| US-5051413-A | For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions | CIBA-GEIGY CORPORATION (US) | 1991-09-24 | — | — | US | disclosed |